Hedge Fund - Brave Warrior Capital
Valeant Pharmaceuticals International Inc. (VRX)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2016 - Q2 (2016-06-30) | $0 | 0% | 0 | $28.31 |
2 | 2016 - Q1 (2016-03-31) | $53,502,000 | 2.6% | 2,034,281 | $73.95 |
3 | 2015 - Q4 (2015-12-31) | $635,549,000 | 25.21% | 6,252,331 | $112.55 |
4 | 2015 - Q3 (2015-09-30) | $994,984,000 | 31.61% | 5,577,892 | $233.19 |
5 | 2015 - Q2 (2015-06-30) | $1,266,479,000 | 36.56% | 5,701,010 | $221.70 |
6 | 2015 - Q1 (2015-03-31) | $1,167,293,000 | 35.63% | 5,877,016 | $177.40 |
7 | 2014 - Q4 (2014-12-31) | $876,779,000 | 30.52% | 6,126,609 | $134.50 |
8 | 2014 - Q3 (2014-09-30) | $864,160,000 | 32.02% | 6,586,582 | $119.20 |
9 | 2014 - Q2 (2014-06-30) | $763,082,000 | 30.77% | 6,050,442 | $127.57 |
10 | 2014 - Q1 (2014-03-31) | $737,267,000 | 29.79% | 5,592,558 | $136.73 |
11 | 2013 - Q4 (2013-12-31) | $717,693,000 | 29.38% | 6,113,227 | $109.57 |
12 | 2013 - Q3 (2013-09-30) | $685,823,000 | 30.77% | 6,573,589 | $97.42 |
13 | 2013 - Q2 (2013-06-30) | $573,073,000 | 26.53% | 6,657,451 | $78.80 |
14 | 2013 - Q1 (2013-03-31) | $494,683,000 | 26.09% | 6,594,015 | $67.20 |
15 | 2012 - Q4 (2012-12-31) | $374,798,000 | 22.45% | 6,270,664 | $56.68 |
16 | 2012 - Q3 (2012-09-30) | $335,107,000 | 20.79% | 6,063,097 | $51.17 |
17 | 2012 - Q1 (2012-03-31) | $236,942,000 | 17.4% | 4,413,146 | $50.92 |
18 | 2011 - Q4 (2011-12-31) | $203,552,000 | 16.52% | 4,359,658 | $41.70 |
19 | 2011 - Q3 (2011-09-30) | $143,177,000 | 13.93% | 3,857,129 | $45.53 |
20 | 2011 - Q2 (2011-06-30) | $183,609,000 | 16.04% | 3,533,654 | $51.68 |
21 | 2011 - Q1 (2011-03-31) | $119,112,000 | 10.18% | 2,391,325 | $39.01 |
The displayed share prices are average quarterly stock market prices.